We evaluated whether black race is independently associated with arterial endothelial dysfunction. The pathophysiological basis for race-related differences in cardiovascular disease (CVD) risk has not been established. Endothelial dysfunction, which precedes obstructive atherosclerotic disease, may contribute to CVD disparities. Accordingly, we evaluated race-related differences in digital pulse amplitude tonometry (PAT) response to an endothelium-dependent vasodilatory stimulus.
Introduction
Racial differences exist in the prevalence of cardiovascular disease (CVD) and its risk factors. Black Americans have among the highest prevalence of hypertension and diabetes mellitus, andwhen compared with whites, have substantially higher risks for acute cardiovascular events. 1, 2 Epidemiological studies indicate that disparities in CVD risk are not fully attributable to racial differences in traditional cardiovascular risk factors. 2, 3 Identification of mechanisms behind these differences may help to develop race-specific risk stratification and prevention strategies. Arterial endothelial dysfunction is a systemic disorder and one of the earliest manifestations in the pathogenesis of atherosclerosis and is associated with CVD events. 4 -7 It results from decreased nitric oxide (NO) bioactivity and is associated with vascular inflammation, vasoconstriction, and thrombosis. 6, 7 Laboratory studies indicate that the steady-state electrochemical balance among NO, superoxide (O 2 2 ), and peroxynitrite (ONOO 2 ) in endothelial cells is closer to the redox state in blacks, a state which is characteristic for endothelial dysfunction. 8 Decreased endothelial function in blacks are well-documented; 9 -13 however, the relative contribution of race as a determinant of endothelial function independent of other risk factors remains to be established. Non-invasive digital pulse amplitude tonometry (PAT) measures endothelial function of the finger arterioles. 14, 15 Pulse amplitude tonometry-detected endothelial dysfunction correlates with coronary and brachial artery endothelial dysfunction, which are predictors of CVD events. 14, 16 Recently, the Framingham Heart Study demonstrated that PAT assessment of arterial reactive hyperaemia is associated with CVD risk factors in a cohort of predominantly white men and women. 17 Traditionally, endothelial function has been measured by flow-mediated dilation (FMD) of the brachial artery. However, PAT is a novel technique which has less operator dependence and may be more convenient as a measure of endothelial function. Pulse amplitude tonometry measures peripheral endothelial function at the level of the finger arterioles. Although data exist in relatively small studies demonstrating racial differences in brachial arterial endothelial function, to date, there are no studies exploring whether there are racial differences in endothelial function at the level of the finger arteries. Accordingly, we sought to explore racial differences in reactive hyperaemia, as measured using PAT, in a large biracial cohort across the entire spectrum of CVD risk.
Methods Participants
The Heart Strategies Concentrating On Risk Evaluation (Heart SCORE) study is a community-based prospective cohort study of 2000 adult participants (54% white, 43% black). Eligibility criteria for Heart SCORE included age 45 -75 years, residence in the Pittsburgh metropolitan area, ability to undergo baseline and annual follow-up visits, and absence of known comorbidities expected to limit life expectancy to ,5 years. Race was self-reported and detailed demographic and medical histories and information on lifestyle characteristics were collected at a baseline visit. Physical examination included vital signs and anthropometric measures. Body mass index (BMI) was calculated as weight in kilograms divided by height in metres squared. Diabetes mellitus was defined as fasting glucose .126 mg/ dL or a history of previously diagnosed diabetes treated with diet, oral agents, and/or insulin. Blood pressure was measured using a standard protocol, as previously described. 18 Hypertension was defined as a systolic blood pressure of .140 mmHg or a diastolic pressure of .90 mmHg, history of physician-diagnosed hypertension, or current use of anti-hypertensive medication. Data on smoking were self-reported. At the baseline visit, fasting blood samples were drawn into tubes containing EDTA by venipuncture. Serum total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol were obtained using the vertical automated profile (Atherotech, Inc., Birmingham, AL, USA). Fasting plasma insulin levels were determined using an immunoenzymatic method (Abbott, Abbott Park, IL, USA) and fasting glucose concentrations were measured by glucose oxidase method. The consumption of fruits and vegetables was evaluated through the PrimeScreen questionnaire. 19 This self-administered diet questionnaire evaluates the quality and frequency of consumption of various foods during the previous year, and the consumption of ≥3 servings per day of fruits and vegetables is associated with an overall healthier diet and lifestyle. 20 The
Lipid Research Clinic Questionnaire 20, 21 was used to evaluate physical activity in the Heart SCORE study, categorizing individuals in three levels of physical activity: very active, moderately active, and inactive. Subjects completed the Center for Epidemiological StudiesDepression Scale (CES-D), in which a CES-D score of 16 or higher reflects a positive screen for Depression. 22, 23 The University of Pittsburgh's Institutional Review Board approved the protocol, and all participants provided written informed consent.
Digital pulse amplitude tonometry
Digital pulse amplitude was measured with a PAT device placed on the tip of each index finger (Endo-PAT2000, Itamar Medical, Caesarea, Israel). 14 -17 The PAT device comprises a pneumatic plethysmograph probe that applies uniform pressure to the surface of the distal finger, allowing measurement of pulse volume changes in the finger. Throughout the study, the inflation pressure of the digital probe was electronically set to 10 mmHg below diastolic blood pressure or 70 mmHg (whichever was lower). Pulse amplitude tonometry signal was measured in the same fashion as in the Framingham study. 17 In brief, baseline pulse amplitude was measured in a fingertip from each arm for 5 min. Arterial flow was interrupted on one side (the study finger) for 5 min by a cuff placed on a proximal forearm at whichever occlusion pressure would be higher: 200 or 60 mmHg above systolic blood pressure. After 5 min of the occlusion the cuff was abruptly deflated and the PAT signal from both hands was recorded for an additional period of 5 min (post-deflation). The contralateral finger was utilized as a control for measuring non-endothelial-dependent systemic changes that might have occurred during the test. Pulse amplitude was recorded electronically in both fingers and analysed by a computerized, automated algorithm (Itamar Medical) that provided the average pulse amplitude for each 30 s interval after forearm cuff deflation up to 5 min. Pulse amplitude tonometry ratio was defined as the natural logarithm of the ratio of post-deflation to baseline averaged PAT signal amplitudes in the hyperaemic finger divided by the same ratio in the contralateral finger that served as control. 17 Specifically, pulse amplitude response to hyperaemia is calculated from the hyperaemic fingertip as the ratio of the post-deflation pulse amplitude to the baseline pulse amplitude [i.e. Xht/Xh0, with X representing pulse amplitude, h denoting hyperaemic finger, t denoting time interval (90 -120 s after cuff release), and 0 denoting baseline]. This result was divided by the corresponding ratio from the contralateral, control hand (i.e. Xct/Xc0, with c denoting the control finger, t denoting time interval, and 0 denoting baseline) to obtain the PAT ratio, which was the primary endpoint of this study. In scatterplots, the relation between baseline and post-deflation variables is not linear and errors are not homoscedastic; therefore, a natural logarithmic transformation of the PAT ratio: PAT ratio ¼ ln[(Xht/Xh0)/(Xct/Xc0)] was used.
Statistical methods
Racial differences in baseline characteristics, including reactive hyperaemia PAT ratio, were evaluated using the Wilcoxon rank sum test for continuous variables and the x 2 test for categorical variables, both in the overall cohort as well as within Framingham risk strata. Linear regression analysis (both univariate and adjusting for demographic and clinical characteristics) was used to further compare vascular measures between blacks with whites (reference). Secondary analysis was carried out to assess race-specific associations between traditional cardiovascular risk factors and PAT ratio. To compliment these Black race is associated with digital artery endothelial dysfunction analyses, formal tests of statistical interaction were performed to evaluate whether race modified associations between clinical factors and PAT ratio. All statistical tests were two-sided with a P-value of ≤0.05 used to define statistical significance. Analyses were performed using the SAS system, version 9.0 (SAS Institute, Cary, NC, USA).
Results

Population characteristics
Of the 1443 black and white participants who agreed to undergo EndoPAT testing, 1377 individuals (41% black) had technically adequate PAT signals. Sixty-six subjects (4.6%) had inadequate PAT data due to incomplete brachial artery occlusion. The baseline clinical characteristics of these participants are detailed in Table 1 . The mean age among the blacks was slightly younger than the whites (58.5 vs. 60.0, P , 0.001) and there were more women in the black cohort (67 vs. 59%, P ¼ 0.004). Compared with whites, blacks tended to be heavier with a greater prevalence of smoking, hypertension, and diabetes. Whites tended to have a greater prevalence of hyperlipidaemia compared with blacks, with higher levels of total cholesterol, triglycerides, and LDL, as well as lower levels of HDL. A significantly greater proportion of blacks, compared with whites, were characterized as high-risk (25.1 vs. 14.4%, P , 0.001) based upon Framingham risk criteria.
In comparison with whites, blacks were more likely to experience depression, to be less active, and to have less healthy dietary habits.
Race-related differences and correlates of endothelial function Figure 1 illustrates the temporal relationship in pulse amplitude as a response to hyperaemic flow, which measures endothelial function, as stratified by both gender and race. After forearm cuff deflation, pulse amplitude in the hyperaemic fingertip peaked in both races and gender between 60 and 90 s, whereas the pulse amplitude in the contralateral (i.e. control) fingertip remained relatively unchanged, as expected. As seen in the figure, the hyperaemic response was greatest in white women followed by white men, black women, and black men, indicating that there exists a continuum of endothelial dysfunction with black men having the most and white women having the least endothelial dysfunction in this unadjusted analysis. In the overall cohort, mean baseline pulse amplitude was not significantly (P ¼ 0.10) different between whites (5.29) and blacks (5.37), as seen in Table 2 . When stratified by gender and race ( Table 2) , black men had higher mean baseline amplitude compared with white men (5.80 vs. 5.57, P ¼ 0.006), although no such difference was noted among females (5.16 vs. 5.09, P ¼ 0.34). Overall, the average PAT ratio was significantly lower in blacks when compared with whites (0.67 + 0.44 vs. 0.80 + 0.46, P , 0.001, Table 2 ). The magnitude of difference by race was larger in men (0.52 + 0.37 vs. 0.74 + 0.41, P , 0.001) than in women (0.75 + 0.45 vs. 0.85 + 0.48, P ¼ 0.002); P-interaction: 0.02. Furthermore, within each race, men had significantly lower PAT ratio than women (P , 0.001), indicating gender differences in endothelial dysfunction.
After adjusting for age and gender, the factors associated with poorer endothelial dysfunction and lower PAT ratio in both whites and blacks included heart rate, BMI, and total cholesterol to HDL cholesterol ratio (data not shown). Being a current smoker was associated with a lower PAT ratio in whites (P ¼ 0.01), but not in blacks (P ¼ 0.93), with a borderline significant test of interaction (P ¼ 0.06).
Fully adjusted assessment of race and pulse amplitude tonometry ratio in men and women
We further assessed the association of gender and race in relation to PAT ratio by adjusting for age, BMI, heart rate, smoking status, history of hypertension, cholesterol to HDL cholesterol ratio, diabetes, depression score, baseline education level, average intake of fruits and vegetables, and physical activity levels ( Table 3) . With white women serving as the referent group, parameter estimates in ascending order were as follows: black males (t ¼ 2 6.93, P , 0.0001); white males (t ¼ 2 3.31, P ¼ 0.001); and black females (t ¼ 2 1.12, P ¼ 0.26). This, like the univariate analyses, can be interpreted as a gradient in endothelial function from high to low: white women . black women . white men . black men. In this model, 13% of the total variation in endothelial function was explained, of which 3% of the 13% was attributed to race and gender.
Race-specific association of risk factors with pulse amplitude tonometry-measured endothelial function Table 4 shows fully adjusted models of the relationships of selected demographic and clinical risk factors with PAT ratio stratified by race. In both blacks and whites, a higher BMI was independently associated with a significantly lower PAT ratio (P , 0.0001), and hence, more endothelial dysfunction. In both races, male gender was significantly associated with a lower PAT ratio; however, this male -female difference appeared to be more pronounced within the black cohort compared with the whites [whites: parameter estimate (SE): 0.10 (0.04), P ¼ 0.01; blacks: parameter estimate (SE): 0.27 (0.04), P , 0.001]. Overall, the demographic and clinical risk factors included in these analyses explained only 12% of the variability in endothelial function in whites and 13% of the variability in blacks. Figure 2 illustrates racial differences in PAT ratio when participants were stratified by Framingham risk (i.e. low-, intermediate-, and high-risk). Within each Framingham risk strata, while there were no statistical differences in baseline pulse amplitude between the two races, blacks had a lower PAT ratio when compared with whites in each risk category. These race-related differences appeared to be more evident in the low-and intermediate-risk 
Racial differences in pat ratio by Framingham risk
Discussion
This study of a large biracial cohort reports three major findings that may explain, in part, the pathophysiology of racial disparities. First, we found that black race is independently associated with arterial endothelial dysfunction of the finger arterioles. Second, we described the correlates of endothelial dysfunction between the two races. Specifically, while male gender was significantly associated with lower PAT ratio in both races, this was more pronounced among blacks. Increasing BMI and increased cholesterol/HDL ratio was associated with lower PAT ratio in both races after adjusted analyses while age was not. Finally, these findings of race-related differences in endothelial dysfunction are evident across the entire spectrum of CVD risk as measured by Framingham risk criteria. Specifically, within each Framingham risk strata (i.e. low, intermediate, or high), blacks consistently had significantly lower PAT ratio than whites. We observed in both races that subjects in the low Framingham risk strata had higher PAT ratios (i.e. better endothelial function) when compared with individuals in the intermediate or high-risk strata. Arterial endothelial dysfunction is an early manifestation of the pathogenesis of atherosclerosis and is primarily caused by loss of endothelium-derived nitric oxide (EDNO) on diseased arteries. 6, 24 In the setting of atherosclerosis, reduced bioavailability of NO in endothelial cells results directly from decreased NO production and indirectly from increased superoxide (O 2 2 ) generation, which reduces NO activity by reacting with NO to produce ONOO 2 , which is critical to atherogenesis. 25 -27 Prior studies reveal race-specific differences in endothelial bioavailability of NO and ONOO ) than those from whites, and as a result, the NO/O 2 2 /ONOO 2 balance in blacks is altered towards the redox state that is associated with endothelial dysfunction, atherosclerosis, and cardiovascular events. 8 Our investigations show that, in contrast to whites, blacks have impaired endothelial function as evidenced by decreased flowmediated PAT hyperaemia. We also examined race-related differences in the contribution of various cardiovascular risk factors towards impaired hyperaemic response in blacks and whites. In both races, several common factors were independently associated *P-value for interaction between gender and PAT differed significantly by race (P ¼ 0.02). The P-value for interaction between other risk factors (age, hypertension, cholesterol, heart rate, smoking, and diabetes) and PAT did not differ significantly by race.
with impaired hyperaemic response, such as male gender, obesity, and the ratio of total to HDL cholesterol. However, our results indicate that among blacks, sex-related differences in endothelial function, which have traditionally been attributed to hormonal differences, are more pronounced. 30, 31 These findings suggest that endothelial function may be modulated, in part, through interactions between gender and race. The Framingham risk scoring classification generally predicts CVD risk accurately in white and black adults. 32 However, it may underestimate risk in certain populations, such as black women, younger individuals, and blacks with hypertension. 32 -34 Our results suggest that even in the low Framingham risk category, there appears to be significant differences in endothelial function among blacks and whites. Therefore, assessment of endothelial dysfunction may provide additional risk stratification to supplement traditional Framingham risk assessment. Prior studies have shown a link between hypertension and endothelial dysfunction. 35 However, like the Framingham study, we found that systolic blood pressure was not significantly associated with digital PAT response. 17 In our study, the prevalence of hypertension was significantly higher among blacks compared with whites. The increased prevalence of hypertension could contribute to race-related differences in endothelial function in blacks; however, it was unexpected that we could not detect any relationship between this risk factor and PAT response. Although the explanation for our findings is not readily apparent, we hypothesize that elevated blood pressure may not significantly impact digital vasomotor function in the finger arterioles. However, several studies have shown an association between hypertension and microcirculatory abnormalities. 36 -39 Given these discrepancies, further studies are warranted to further evaluate the mechanisms behind hypertension and endothelial function. Age is associated with large artery endothelial dysfunction.
40,41
However, we did not find an association between age and hyperaemic PAT response of the small finger arterioles. This finding suggests that small vs. large artery endothelial dysfunction may have different determinates. Indeed, the Framingham investigators observed a paradoxical positive correlation between age and PAT response. 17 These contradictory results and the lack of observing the expected negative correlation between age and PAT response in either study warrants further examination. Our study did not observe significant association between diabetes and arterial endothelial function, which contrasts with findings from the predominantly white Framingham cohort. 17 Our findings may be attributed to the higher prevalence of diabetes in our study (16% among blacks and 5.8% among whites) when compared with the Framingham cohort in which only 3% of subjects had diabetes mellitus. The higher-risk characteristics of our population, and particularly, the higher prevalence of diabetes, may have attenuated the differences in vasomotor tone with respect to the influence of diabetes upon PAT response. The three-fold higher prevalence of diabetics in blacks may explain, in part, the racial difference in endothelial dysfunction. Racial differences in endothelial dysfunction measured by other vascular measures have been previously described. Brachial artery FMD, which is a common measure of large artery endothelial dysfunction, is known to be lower in blacks compared with whites. 9 -13 However, this finding may be attributed to the fact that baseline brachial artery diameter, which influences the calculation of FMD, varies by race, with black race being associated with larger baseline brachial artery diameter, 10 although the contribution of race upon FMD persists even after taking into account baseline differences in brachial artery diameter. 9 Nevertheless, in this context, it is notable that we found no significant differences between blacks and whites with respect to baseline pulse amplitude in finger arterioles, but we did observe that blacks have significantly lower pulse amplitude response to an endotheliumdependent stimulus. Therefore, the observed differences in PAT ratio between whites and blacks are driven by differential arteriolar vasodilator responses to hyperaemia due to underlying racial differences in endothelial function.
Study limitations
Our study represents a cross-sectional analysis. endothelial dysfunction manifested by impaired hyperaemic vascular response to endothelium-dependant stimuli. We did not directly evaluate arteriolar endothelium-independent response by measuring responses to an infusion of an endothelium-independent vasodilator in the forearm. However, prior studies have validated the EndoPAT as a measure of peripheral and coronary endothelial dysfunction. 14 -16 Finally, our study was limited to the evaluation of endothelial dysfunction of the finger vascular bed that is mostly composed of micro-circulation. Nevertheless, our findings that black race is independently associated with arteriolar endothelial dysfunction are likely to be generalizable to the arterial circulation as a whole because of the systemic nature of atherogenesis. 
Conclusions
This study of a large cohort of black and white Americans indicates that black race is independently associated with endothelial dysfunction. These racial differences exist across the entire spectrum of cardiovascular risk, as assessed by the Framingham risk classification. Furthermore, we found that the gender differences in arterial endothelial function are more prominent in blacks than whites, suggesting that race and gender interact to modulate endothelial dysfunction. Given that endothelial dysfunction is known to be associated with increased CVD risk, our findings suggest that racial differences in CVD may be related, in part, to race-related differences in the pathophysiology of endothelial function. Further studies are warranted to evaluate the clinical implications of as well as the potential mechanisms behind these findings.
